Restoration of normal experimental DNCB hypersensitivity development in symptom-free patients with psoriasis.
D004137:Dinitrochlorobenzene / Q000276:immunology*; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007114:Immunization; D009578:Nitrobenzenes / Q000276:immunology*; D011565:Psoriasis / Q000276:immunology*; D012397:Rosette Formation; D013997:Time Factors
D004137:Dinitrochlorobenzene; D009578:Nitrobenzenes